News Category: Regulatory news
We have published an updated Q&A document relating to the impact of the Windsor Framework on the regulation of human medicines.
The document is based on questions the HPRA has received from companies and includes updated information on joint labels between IE/UK.
Further questions on this topic can be sent to brexit@hpra.ie. We will continue to update the document as necessary.